histamine h1 antagonists

Preferred Label : histamine h1 antagonists;

MeSH definition : Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.;

MeSH synonym : antagonists, histamine h1 receptor; histamine h1 blockers; h1 antihistaminics; h1 receptor blockaders; histamine h1 receptor blockaders; blockaders, histamine h1 receptor; histamine h1 receptor antagonists; h1 antagonists, histamine; antihistaminics, h1; receptor blockaders, h1; antagonists, histamine h1; Histamine H1 Receptor Antagonist; Histamine H1 Antagonist; Antagonist, Histamine H1; H1 Antagonist, Histamine;

CISMeF synonym : h1 blockers, histamine; blockers, histamine h1; blockaders, h1 receptor;

MeSH hyponym : antihistamines, classical; Classical Antihistamines; Antihistaminics, Classical; Classical Antihistaminics; First Generation H1 Antagonists; Antihistamines, Sedating; Sedating Antihistamines;

MeSH annotation : HISTAMINE H1 ANTAGONISTS, NON-SEDATING is also available; DF: HISTAMINE H1 ANTAG; HISTAMINE H1 ANTAGONISTS, NON-SEDATING is also available;

Wikipedia link : https://en.wikipedia.org/wiki/Histamine h1 antagonists;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D006634;

UMLS CUI

C0019592;

ATC code(s)
- deptropine [ATC Code]
- desloratadine [ATC Code]
- dimenhydrinate [ATC Code]
- ebastine [ATC Code]
- epinastine [ATC Code]
- pimethixene [ATC Code]
- tritoqualine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- First-generation antihistamine [ICD-11 Extension code]
- Sedating antihistamine (product) [Inactive SNOMED CT concept]
- Sedating antihistamine (substance) [Inactive SNOMED CT concept]
CISMeF manual mappings
- Substance with histamine H1 receptor antagonist mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Histamine H1 receptor antagonist (disposition) [SNOMED CT concept]
- Histamine-1 Receptor Antagonist [NCIt concept]
- Substance with histamine receptor antagonist mechanism of action (substance) [SNOMED CT concept]
- antihistamine, nos [BNCI treatment]
- antihistamine, nos [SNOMED Notion]
Indexing information
- 2-(3-(4-methylpiperazin-1-yl)propylthio)-3-(2-methylphenyl)quinazolin-4(3H)-one [MeSH Supplementary Concept]
- 4-((4-chlorophenyl)methyl)-2-((1-(4-(4-((3-(hexahydro-1H-azepin-1-yl)propyl)oxy)phenyl)butyl)-2-pyrrolidinyl)methyl)pyrido(3,4-d)pyridazin-1(2H)-one [MeSH Supplementary Concept]
- GSK 1004723 [MeSH Supplementary Concept]
- HG 37-639 [MeSH Supplementary Concept]
- mepyramine-BODIPY630-650 [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- Other H1-receptor antagonists [Bloc CIM-11]
Manual NTBT mappings (CISMeF)
- Substance with histamine receptor antagonist mechanism of action (substance) [SNOMED CT concept]
MeSH Descriptor(s) used for indexing
- receptors, histamine h1 [MeSH Descriptor]
Record concept(s)
- antihistamines, classical [MeSH concept]
- histamine H1 antagonists [MeSH concept]
See also
- anti-allergic agents [MeSH Descriptor]
- bronchodilator agents [MeSH Descriptor]
- hypersensitivity, immediate [MeSH Descriptor]
- hypnotics and sedatives [MeSH Descriptor]
See also (suggested by CISMeF)
- flunarizine [MeSH Descriptor]
See also inter- (CISMeF)
- Antihistamines [LOINC component]
- Product containing histamine H1 receptor antagonist (product) [SNOMED CT concept]
- Product containing histamine receptor antagonist (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 5,6-dihydrospiro(11H-imidazo(2,1-b)(3)benzazepine-11,4'-piperidine)-3-carboxamide [MeSH Supplementary Concept]
- Mirtazapine [MeSH Descriptor]
- NCO 650 [MeSH Supplementary Concept]
- alcaftadine [MeSH Supplementary Concept]
- antazoline [MeSH Descriptor]
- azatadine [MeSH Supplementary Concept]
- azatadine maleate, pseudoephedrine sulfate drug combination [MeSH Supplementary Concept]
- brompheniramine [MeSH Descriptor]
- carbinoxamine [MeSH Supplementary Concept]
- carbinoxamine, dextromethorphan, pseudoephedrine drug combination [MeSH Supplementary Concept]
- carebastine [MeSH Supplementary Concept]
- chloropyramine [MeSH Supplementary Concept]
- chlorpheniramine [MeSH Descriptor]
- chlorpheniramine, ephedrine drug combination [MeSH Supplementary Concept]
- cinnarizine [MeSH Descriptor]
- clemastine [MeSH Descriptor]
- cyclizine [MeSH Descriptor]
- cyproheptadine [MeSH Descriptor]
- dexbrompheniramine [MeSH Supplementary Concept]
- dexchlorpheniramine [MeSH Supplementary Concept]
- dibenzheptropine [MeSH Supplementary Concept]
- dicyclomine, doxylamine, pyridoxine drug combination [MeSH Supplementary Concept]
- dimenhydrinate [MeSH Descriptor]
- dimethindene [MeSH Descriptor]
- diphenhydramine [MeSH Descriptor]
- doxylamine [MeSH Descriptor]
- doxylamine succinate [MeSH Supplementary Concept]
- ebastine [MeSH Supplementary Concept]
- embramine [MeSH Supplementary Concept]
- emedastine [MeSH Supplementary Concept]
- epinastine [MeSH Supplementary Concept]
- flunarizine [MeSH Descriptor]
- fonazine [MeSH Supplementary Concept]
- histabudifen [MeSH Supplementary Concept]
- histapendifen [MeSH Supplementary Concept]
- hydroxyzine [MeSH Descriptor]
- isospaglumic acid [MeSH Supplementary Concept]
- ketotifen [MeSH Descriptor]
- lodoxamide tromethamine [MeSH Supplementary Concept]
- meclizine [MeSH Descriptor]
- mequitazine [MeSH Supplementary Concept]
- methapyrilene [MeSH Descriptor]
- mianserin [MeSH Descriptor]
- oxatomide [MeSH Supplementary Concept]
- phenindamine [MeSH Supplementary Concept]
- pheniramine [MeSH Descriptor]
- picumast [MeSH Supplementary Concept]
- promethazine [MeSH Descriptor]
- protopine [MeSH Supplementary Concept]
- proxicromil [MeSH Supplementary Concept]
- pseudoephedrine, triprolidine drug combination [MeSH Supplementary Concept]
- pyrilamine [MeSH Descriptor]
- temelastine [MeSH Supplementary Concept]
- tranilast [MeSH Supplementary Concept]
- trimeprazine tartrate [MeSH Supplementary Concept]
- tripelennamine [MeSH Descriptor]
- triprolidine [MeSH Descriptor]
- tritoqualine [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Histamine-1 Receptor Antagonist [NCIt concept]
- Product containing histamine H1 receptor antagonist (product) [SNOMED CT concept]
- Substance with histamine H1 receptor antagonist mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients